Eyal Attar
2023
In 2023, Eyal Attar earned a total compensation of $1.4M as Chief Medical Officer at Vor Biopharma.
Compensation breakdown
| Non-Equity Incentive Plan | $180,286 |
|---|---|
| Option Awards | $437,090 |
| Salary | $474,000 |
| Stock Awards | $302,475 |
| Other | $6,269 |
| Total | $1,400,120 |
Attar received $474K in salary, accounting for 34% of the total pay in 2023.
Attar also received $180.3K in non-equity incentive plan, $437.1K in option awards, $302.5K in stock awards and $6.3K in other compensation.
Rankings
In 2023, Eyal Attar's compensation ranked 843rd out of 2,983 executives tracked by ExecPay. In other words, Attar earned more than 71.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 843 out of 2,983 | 72nd |
Division Manufacturing | 492 out of 1,637 | 70th |
Major group Chemicals And Allied Products | 334 out of 906 | 63rd |
Industry group Drugs | 325 out of 869 | 63rd |
Industry Biological Products, Except Diagnostic Substances | 102 out of 211 | 52nd |
Source: SEC filing on April 9, 2024.
Attar's colleagues
We found two more compensation records of executives who worked with Eyal Attar at Vor Biopharma in 2023.